dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp07414

General Description

Peptide name : Si2

Source/Organism : Synthetic

Linear/Cyclic : Linear

Chirality : L

Sequence Information

Sequence : KL(Beta-A)KL(Beta-A)K

Peptide length: Not available

C-terminal modification: Linear

N-terminal modification : Amidation

Non-natural peptide information: β-Ala

Activity Information

Assay type : MTT assay

Assay time : 72-h

Activity : IC50 = 662.9 ± 20.02 µM

Cell line : MCF-7

Cancer type : Breast Cancer

Other activity : Antimicrobial and Anticancer

Physicochemical Properties

Amino Acid Composition Bar Chart : Not available

Molecular mass : Not available

Aliphatic index : Not available

Instability index : Not available

Hydrophobicity (GRAVY) : Not available

Isoelectric point : Not available

Charge (pH 7) : Not available

Aromaticity : Not available

Molar extinction coefficient (cysteine, cystine): Not available

Hydrophobic/hydrophilic ratio : Not available

hydrophobic moment : Not available

Missing amino acid : Not available

Most occurring amino acid : Not available

Most occurring amino acid frequency : Not available

Least occurring amino acid : Not available

Least occurring amino acid frequency : Not available

Structural Information

3D-structure: Not available

Secondary structure fraction (Helix, Turn, Sheet): Not available

SMILES Notation: Not available

Secondary Structure :

Method Prediction
GOR Not available
Chou-Fasman (CF) Not available
Neural Network (NN) Not available
Joint/Consensus Not available

Molecular Descriptors and ADMET Properties

Molecular descriptors: Not available

ADMET properties: Not available

Cross Referencing Databases databases

Pubmed Id : 33567789.0, .

Uniprot : Not available

CancerPPD : Not available

ApIAPDB : Not available

Reference

1 : Jaber S, et al. Synthesis, Antitumor and Antibacterial Studies of New Shortened Analogues of (KLAKLAK)<sub>2</sub>-NH<sub>2</sub> and Their Conjugates Containing Unnatural Amino Acids. Molecules. 2021; 26:(unknown pages). doi: 10.3390/molecules26040898

Literature

Paper title : Synthesis, Antitumor and Antibacterial Studies of New Shortened Analogues of (KLAKLAK)<sub>2</sub>-NH<sub>2</sub> and Their Conjugates Containing Unnatural Amino Acids.

Doi : https://doi.org/10.3390/molecules26040898

Abstract : (1) Background: (KLAKLAK)<sub>2</sub> is a representative of the antimicrobial peptide group which also shows good anticancer properties. (2) Methods: Herein, we report synthesis using SPPS and characterization by HPLC/MS of a series of shortened analogues of (KLAKLAK)<sub>2</sub>. They contain single sequence KLAKLAK as C-terminal amides. In addition, substitution of some natural amino acids with unnatural β-Ala and nor-Leu is realized. In addition, these structures are conjugated with second pharmacophore with well proven anticancer properties 1,8-naphthalimide or caffeic acid. Cytotoxicity, antiproliferative effect and antimicrobial activity of newly synthesized structures were studied. (3) Results: The obtained experimental results reveal significant selective index for substances with common chemical structure KLβAKLβAK-NH<sub>2</sub>. The antibacterial properties of newly synthesized analogues at two different concentrations 10 μM and 20 μM, were tested against Gram-negative microorganisms Escherichia coli K12 407. Only two of the studied compounds KLAKLAK-NH<sub>2</sub> and the one conjugated with second pharmacophore 1,8-naphthalimide and unnatural amino acid nor-Leu showed moderate activity against tested strains at concentration of 20 μM. (4) Conclusions: The obtained results reveal that the introducing of 1,8-naphthalimideGly- and Caf- increase the cytotoxicity and antiproliferative activity of the peptides but not their selectivity. Only two compounds KLAKLAK-NH<sub>2</sub> and 1,8-naphthalimideGKnLAKnLAK-NH<sub>2</sub> show moderate activity against Escherichia coli K12 at low concentration of 20μM.